Share: Share on Facebook Share on Twitter Share on LinkedIn I recommend visiting to read:%0A%0A {0} %0A%0A {1}
Life Sciences Golden Triangle Report Life Sciences Golden Triangle Report

Life Sciences: Golden Triangle Lab Report

Jamie Renison • 02/05/2024
Our latest Life Sciences Lab Report on the UK's Golden Triangle. The report External Link looks closely at investment volumes, leasing take up, lab supply and pipeline, and investment into life sciences real estate across Cambridge, Oxford and London. 
Q4 2023 Take-Up Statistics
  • Golden Triangle leasing activity totalled 169,000 sq ft in Q1 2024.
  • Whilst a step down from the 364,000 leased in Q4 2023, it remained 5% above the five-year quarterly average.
Evolving Demand and Supply
  • There is 2.8 million sq ft of life sciences space under construction across the Golden Triangle.
  • 24% of supply under construction is pre-let or under offer.
  • A slowdown in venture capital markets alongside a string of recent completions brought a modest easing in the demand-supply imbalance
  • Prime headline quoting rents in Q1 2024 increased by 8% in Cambridge to £70.00 psf while Oxford and London held firm at £62.50 in Oxford and £130.00 respectively.
Venture Capital
  • The first quarter of the year reported £641.2 million of venture capital (VC) funding invested into UK life sciences companies, up 3% on the five-year quarterly average.
  • Investors are opting to invest in fewer companies overall but with larger average size for the relevant funding stage. In Q1 2024, the average funding package was £13.9 million, 29% above the five-year average.
  • The global IPO market had its best quarter since Q1 2022, which is likely to encourage VC dry powder into the market.
Investment Market Insights
  • A total of £192.5 million of life sciences real estate transacted across the Golden Triangle in Q1 2024.
  • While this was over double Q4 2023 and represented the highest quarterly figure since Q1 2023, the high-interest-rate environment is keeping volumes subdued.
  • Looking forward to later in 2024, a pipeline of transactions in the offing has the potential, if they successfully transact, to increase the number and volume of deals to the above-average levels seen in Q1 2023.

Read more in our latest quarterly report External Link or get in touch with a member of the team to discuss further.


life sciences

Life Sciences Update

The life sciences industry enters 2024 with measured optimism, signaling that the sector has reverted to its long-term trend for growth. A flurry of recent announcements, from strong initial public offerings to exciting new mergers and acquisitions, has breathed new life into the industry.
Sandy Romero • 06/03/2024
GSK Completes Sale Of Strategic Life Sciences Development Site

Real estate services firm Cushman & Wakefield has advised GSK plc on the sale of the surplus development land that sits alongside its 1 million sq ft Research & Development (R&D) facility in Stevenage to UBS Asset Management and Reef Group. 


Life Sciences Real Estate Services
We help life science companies create flexible real estate strategies to attract and retain top talent, while managing efficiency and costs.
Learn More

Ready to talk?

Get in touch with one of our professionals.
With your permission we and our partners would like to use cookies in order to access and record information and process personal data, such as unique identifiers and standard information sent by a device to ensure our website performs as expected, to develop and improve our products, and for advertising and insight purposes.

Alternatively click on More Options and select your preferences before providing or refusing consent. Some processing of your personal data may not require your consent, but you have a right to object to such processing.

You can change your preferences at any time by returning to this site or clicking on Cookies.
Agree and Close
These cookies ensure that our website performs as expected,for example website traffic load is balanced across our servers to prevent our website from crashing during particularly high usage.
These cookies allow our website to remember choices you make (such as your user name, language or the region you are in) and provide enhanced features. These cookies do not gather any information about you that could be used for advertising or remember where you have been on the internet.
These cookies allow us to work with our marketing partners to understand which ads or links you have clicked on before arriving on our website or to help us make our advertising more relevant to you.
Agree All
Reject All